Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence
Positive AMERK baseline levels were correlated with younger age at MCC diagnosis and nonhead and neck tumor location, possibly related to the distribution of viral etiology. A specific post-RT AMERK decline correlating with EFS could not be identified.
Authors
- Manisha Thakuria (ORCID: https://orcid.org/0000-0002-9024-9090)
- Kevin X. Liu (ORCID: https://orcid.org/0000-0003-2071-5137)
- Kee‐Young Shin (ORCID: https://orcid.org/0000-0002-3451-8516)
- Charles H. Yoon (ORCID: https://orcid.org/0000-0003-1231-3840)
- Jonathan D. Schoenfeld (ORCID: https://orcid.org/0000-0002-5119-0401)
- E. Fité (ORCID: https://orcid.org/0009-0000-9396-3110)
- Ann W. Silk (ORCID: https://orcid.org/0000-0003-3877-3984)
- Roy B. Tishler (ORCID: https://orcid.org/0000-0002-0012-6055)
- Danielle N. Margalit (ORCID: https://orcid.org/0000-0002-8281-0829)
Institutions
- Brigham and Women's Hospital (US)
- Women's Hospital (US)
- Dana-Farber Cancer Institute (US)
- Dana-Farber Brigham Cancer Center (US)
Publication Details
- Journal
- Cancer
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1002/cncr.35507
- Citations
- 2
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Regeneron Pharmaceuticals
- Castle Biosciences
- Natera
- National Institutes of Health
- Genentech
- EMD Serono